Chapel Hill startup targets seed funding after working to diversify Novavax Covid-19 vaccine trial
May 17, 2021 at 11:41 AM EDT
A Chapel Hill startup with UNC ties is looking to raise cash to grow its headcount as it aims to help clinical trials become more diverse.